HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome.

AbstractBACKGROUND:
Tumours arising in younger women appear to be biologically more aggressive and tend to have a poorer outcome. Being relatively resistant to conventional treatments, breast cancer stem cells (CSCs) have been postulated as a possible cause of disease recurrence after treatment. In this study, we used ALDH1 as a CSC marker and determined whether ALDH1 expression correlated with clinical outcome in young women with breast cancer.
METHODS:
The expression of ALDH1 was evaluated through immunohistochemistry on microarrayed cores obtained from 141 consecutive patients up to 35 years of age.
RESULTS:
The expression of ALDH1 was observed in 25% (35 of 141) of tumours, in a median of 5% of cells. Younger women were 14 times more likely to have ALDH1-positive tumours (P<0.01, OR 14.4, 95% CI 4.34-48.09). The ALDH1 correlated independently with ER negativity (P=0.01, OR 0.33, 95% CI 0.15-0.77). There was no correlation with disease recurrence or breast cancer-related deaths.
CONCLUSION:
In younger women, ALDH1 was more highly expressed, and it correlated with ER negativity. It, however, did not predict survival in this study.
AuthorsE Y Tan, A A Thike, Breast Surgical Team at Outram, P H Tan
JournalBritish journal of cancer (Br J Cancer) Vol. 109 Issue 1 Pg. 109-13 (Jul 09 2013) ISSN: 1532-1827 [Electronic] England
PMID23787917 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Isoenzymes
  • Receptors, Estrogen
  • Aldehyde Dehydrogenase 1 Family
  • ALDH1A1 protein, human
  • Retinal Dehydrogenase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aldehyde Dehydrogenase 1 Family
  • Biomarkers, Tumor (metabolism)
  • Breast Neoplasms (enzymology, mortality)
  • Female
  • Humans
  • Isoenzymes (metabolism)
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplastic Stem Cells (metabolism)
  • Receptors, Estrogen (metabolism)
  • Retinal Dehydrogenase (metabolism)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: